interaction records 54 assistance programs 55 0 personal data stored

Generic competition · all medicines · read 12 November 2026

Is there a generic of Atomoxetine Hydrochloride, and who makes it?

Atomoxetine Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 9 generic makers listed as marketed across them. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming. Where both are dated, the first generic approval came 7.8 years after the first brand approval. This is the Orange Book's listing, not a forecast.

Compiled and checked by Vincent Wesley Couey (ORCID 0009-0005-6869-308X) from the Orange Book data files, downloaded 12 November 2026.

Not medical advice. This page reports what the FDA's Orange Book lists, not what a pharmacy has in stock, what anything costs, or whether a generic is right for you. Ask your pharmacist or prescriber about your own medicine.
Atomoxetine Hydrochloride2 dosage-form groups in the Orange Book
9generic makers listed
  1. Atomoxetine Hydrochloride appears in 2 dosage-form groups in the FDA Orange Book as of 12 November 2026, with 9 generic makers listed as marketed across them.
  2. 1 group has a brand listed as marketed and no generic listed as marketed. The data does not state why, and it does not state that one is coming.
  3. Where both are dated, the first generic approval came 7.8 years after the first brand approval.
  4. Patents and exclusivities are shown as listed by the application holder; the Orange Book does not rule on them, and a listed patent is not a statement that a generic is blocked. This says nothing about price, supply or quality.

Capsule, Oral

Four or more generic makers listed

Every brand product here is listed as discontinued. 9 generic makers with 63 generic products listed as marketed; the first generic approval is dated 16 September 2010.

200020052010201520202025203009brand 2002Zydus Pharmaceuticals Usa Inc, first approval 16 September 2010Apotex Inc, first approval 30 May 2017Aurobindo Pharma Ltd, first approval 30 May 2017Glenmark Pharmaceuticals Ltd, first approval 30 May 2017Teva Pharmaceuticals Usa, first approval 30 May 2017Dr Reddys Laboratories Ltd, first approval 23 February 2018Strides Pharma Global Pte Ltd, first approval 18 February 2021Hetero Labs Ltd Unit V, first approval 11 March 2021Pharmazone, first approval 16 June 2026data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end
Generic maker (applicant)First approvalProducts
Zydus Pharmaceuticals Usa Inc16 September 20107
Apotex Inc30 May 20177
Aurobindo Pharma Ltd30 May 20177
Glenmark Pharmaceuticals Ltd30 May 20177
Teva Pharmaceuticals Usa30 May 20177
Dr Reddys Laboratories Ltd23 February 20187
Strides Pharma Global Pte Ltd18 February 20217
Hetero Labs Ltd Unit V11 March 20217
Pharmazone16 June 20267

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

Solution, Oral

Brand listed, no generic listed as marketed

Brand listed as marketed: Atoncy. No generic is listed as marketed.

20202025203001brand 2026data date
generic makers listed as marketed, by first approvallisted patent expiryexclusivity end

Patents and exclusivities still listed

No unexpired patent or exclusivity is listed against the marketed brand products in this group.

US Food and Drug Administration, Orange Book data files, downloaded 12 November 2026. A listed patent is not a ruling that a generic is blocked, and no figure here says anything about price, supply or quality. Check the Orange Book.

Where can you go from this result?

Open it in the check to search another medicine, or see every brand with no generic listed. The FDA explains generic approval in how generic drugs are approved and the FDA generic drug facts, and the Orange Book itself is the FDA Orange Book. To check what is available now, ask your pharmacist, and see the FDA drug shortages page.